Delivering a Diversified Long-term Revenue Stream

Fortress Biotech, Inc. is an innovative biopharmaceutical company focused on delivering a diversified, long-term revenue stream to our shareholders through the creation of a diverse portfolio of marketed products, as well as in-licensing opportunities and through the development of high-potential preclinical and clinical-stage product candidates. Fortress currently has seven marketed products and over 20 programs in development.

Recent Event

2024 Annual Meeting of Stockholders

Latest Financial Results

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2023

mail icon

Sign Up for Email Alerts

Receive updates straight into your inbox

Sign up today

About Fortress Biotech

Fortress Biotech, Inc. (“Fortress”) is an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue, equity holdings and dividend and royalty revenue. The company has seven marketed prescription pharmaceutical products and over 20 programs in development at Fortress, at its majority-owned and majority-controlled partners and subsidiaries and at partners and subsidiaries it founded and in which it holds significant minority ownership positions. Fortress’ portfolio is being commercialized and developed for various therapeutic areas including oncology, dermatology, and rare diseases. Fortress’ model is focused on leveraging its significant biopharmaceutical industry expertise and network to further expand and advance the company’s portfolio of product opportunities. Fortress has established partnerships with some of the world’s leading academic research institutions and biopharmaceutical companies to maximize each opportunity to its full potential, including AstraZeneca, City of Hope, Fred Hutchinson Cancer Center, Nationwide Children’s Hospital and Sentynl. For more information, visit

Fortress Biotech at a Glance


Programs in Development


Marketed Products

Fortress Biotech Performance

Year over year company performance

As of Dec. 31, 2023 • 10-K 2023

Investor Relations Contacts


Fortress Biotech, Inc.
1111 Kane Concourse
Suite 301
Bay Harbor Islands, FL 33154

Investor Relations

Jaclyn Jaffe
Nicole McCloskey
T: 781-652-4500

Transfer Agent

VStock Transfer, LLC
18 Lafayette Place
Woodmere, NY 11598
T: 212-828-8436